BIOT:SW L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF

CHF 8.79 0.01 0.091116
Icon

L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (BIOT:SW) Stock Analysis and Price Targets

ETF | Others | SW
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

CHF 8.79

+0.01 (+0.09)%

N/A

7.00

CHF -1.00

N/A

Icon

BIOT:SW

L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (CHF)
ETF | SW
CHF 8.79
0.00 0
Take a Tour

L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF (BIOT:SW) Stock Forecast

N/A

Based on the L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF stock forecast from 0 analysts, the average analyst target price for L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF is not available over the next 12 months. L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF is Very Bearish, which is based on 0 positive signals and 3 negative signals. At the last closing, L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF’s stock price was CHF 8.79. L&G Pharma Breakthrough UCITS ETF USD Accumulating ETF’s stock price has changed by +2.98% over the past week, +1.58% over the past month and -15.69% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...